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Background: Electronic AKI alerts highlight changes in serum creatinine compared to  ǯ  Ǥ    to identify all AKI alerts and describe the 
relationship between electronic AKI alerts and outcome for AKI treated in the Intensive 
Care Unit (ICU) in a national multicentre cohort.   
Methods: A prospective cohort study was undertaken between November 2013 and 
April 2016, collecting data on electronic AKI alerts issued.   
Results: 10% of 47,090 incident AKI alerts were associated with ICU admission. 90-day 
mortality was 38.2%.  Within the ICU cohort 48.8% alerted in ICU. 51.2% were 
transferred to ICU within 7 days of the alert, of which 37.8% alerted in a hospital setting 
(HA-AKI) and 62.2% in a community setting (CA-AKI). Mortality was higher in patients 
transferred to ICU following the alert compared to those who had an incident alert on 
the ICU (p<0.001), and was higher in HA-AKI (45.3%) compared to CA-AKI (39.5%) 
(35.0%, p=0.01).  In the surviving patients, the proportion of patient recovering renal 
function following, was significantly higher in HA-AKI alerting (84.2%, p=0.004) and 
CA-AKI alerting patients (87.6%, p<0.001) compared to patients alerting on the ICU 
(78.3%).  
Conclusion: Using AKI e-alerts provides a centralised resource which does not rely on 
clinical diagnosis of AKI or coding, resulting in a robust data set which can be used to 
define the incidence and outcome of AKI in the ICU setting.   
 
Key Words 
Acute kidney injury, AKI, electronic alerts, Intensive care, ICU 
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Background 
Acute Kidney injury (AKI) is a common complication in seriously ill patients which is 
associated with significant morbidity and mortality.  AKI in the Intensive Care Unit 
(ICU) has different pathophysiological mechanisms and outcomes compared to AKI in a 
non-ICU population.  Many previously published studies characterising AKI in ICU rely 
on clinical diagnosis, hospital coding or retrospective review of hospital records to 
identify cases (1-4).   
In  2009, the National Confidential Enquiry into Patient Outcome and Death (NCEPOD) 
(5) report identified significant deficiencies in the management of AKI in hospitals in 
the U.K.  This led to the development and implementation of strategies such as the use 
of electronic results reporting to aid early AKI recognition (6) although to date there is 
no evidence that implementation of this strategy improved clinical outcome (7).  An 
automated real time electronic (e)-alert for detection of AKI based on the Kidney 
Disease: Improving Global Outcomes (KDIGO) change in creatinine diagnostic criteria 
has been agreed and implemented nationally across all areas of the National Health 
Service in Wales and England (U.K.) (8).  This automatically compares measured serum 
creatinine (SCr) values on an individual patient against previous results on the system 
database.  The use of a ǯ own historical creatinine data although providing and 
accurate baseline estimation of renal function does not meet the strict diagnostic 
criteria for AKI requiring an acute rise within 48hours.  In order to understand the 
possible implication of an AKI e-alert in the context of the ICU, in the current manuscript 
we have therefore used our centralised system of national data collection and a 
creatinine based AKI alerts to describe the relationship between electronic AKI alerts, 
ICU admission and outcome.   
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 4 
Methods 
Setting:  Data were collected across the National Health Service in Wales, serving a total     ?Ǥ ? Ǥ      ǲ ǳǤ 
Development of Electronic Reporting System:  The previously described Welsh 
electronic AKI reporting system (9), utilizes an algorithm based on changes in serum 
creatinine level (Supplementary Figure 1).  AKI is identified by automatically comparing 
measured creatinine values from an individual patient against previous results in real 
time.   ǲǳ           
which the baseline creatinine is obtained. Rule 1 alerts represent a >26µmol/l increase 
in SCr within the previous 48 hours and are issued only if rule 2 and rule 3 are not Ǥ ? ? ? ? ? ?ǡ
a   ?     ? ? ? ?          
previous 8 to 365 days (8). 
Data Collection:  ȋ ? ? ?Ȍ
between November 2013 and April 2016. An incident episode was defined as 90 days.  
For each episode the clinical location, patient age, AKI stage and the rule under which 
the AKI alert was generated was collected together with all measurements of renal 
function for up to 90 days following the AKI alert. To be included in the ICU cohort 
patients had to have either alerted in ICU, or be transferred to ICU within 7 days of the 
alert.  
Patients with an e-alert generated during a hospital admission with a baseline SCr from 
a hospital setting within the preceding seven days were defined as Hospital-acquired 
(HA)-AKI. Patients alerting in a non-inpatient setting (including Accident and 
Emergency/Acute assessment units) or in primary care were classified as community-
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acquired (CA)-AKI.  Patients in whom alerts were generated in an inpatient setting but 
with no results available for the previous 7 days were excluded from the CA- and HA-
AKI subgroup analyses.  Progression of AKI was defined as a peak AKI stage higher than 
the incident e- ? ? ? ? ?
alert. 
Mortality data were collected from the Welsh Demographic Service.  Patients were 
censored at 27 months for survival analysis. Renal outcome analysis required patients 
to have 90 day follow up data.  Non-recovery was defined as a SCr value measured at 90 
days still consistent with AKI when compared to original baseline.  Pre-existing chronic 
kidney disease (PeCKD) was defined as an eGFR (CKDEpi eGFR (15)) 
<60ml/min/1.73m2 derived from the baseline SCr.   
Statistical analysis was carried out using SPSS software, version 20 (SPSS, Inc., Chicago, ȌǤ ǯ       ributed data. Categorical data were 
compared using a Pearson chi-squared test. Multivariate Cox proportional hazard 
modelling was used to analyse outcome.   
 
Results 
We observed a total of 146,512 alerts, representing 47,090 incident AKI alerts. 10.0% of 
all episodes were associated with ICU admission.  Demographic data on AKI episodes 
requiring ICU are shown in Table 1.  Ninety-day mortality was 38.2%.  Analysis of the 
surviving cohort demonstrated recovery from the acute episode occurred in 82.3% of 
all incident ICU alerts. 
 
Comparison of AKI alerts generated in the community, in a hospital in-patient 
setting and on the ICU.  
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Demographic data on all AKI incident alerts requiring ICU by cohort are shown in Table 
3.  Of all patients with an e-alert requiring ICU, 2,318 (48.8%) alerted in ICU.   2,428 
(51.2%) were transferred to ICU within 7 days of the alert of which 37.8% alerted in a 
hospital setting and 62.2% in a community setting.  Although classified as CA-AKI it is of 
note that 23.9% of these patient had a measurement of renal function as an inpatient in 
the preceding 9.8±8.6days, and 20.1% had a measurement of renal function in an A&E 
setting in the preceding 4.9±6.9days.   
AKI severity as determined by the AKI stage of the incident alert was significantly worse 
for CA-AKI alerts followed by HA-AKI and AKI alerting in ICU.  The proportion of patient 
presenting with a AKI stage 2/3 alerts at presentation was 15.5% in patients alerting on 
the ICU, 25.1% in HA-AKI alerting patients and 47.8% CA-AKI alerting patients 
(p<0.001). 
CA-AKI alerting patients were least likely to experience deterioration of renal function 
following its initial identification by alert, and HA-AKI alerting patients most likely 
(p<0.001).  
Mortality was significantly higher in patients transferred to ICU (41.7%) following the 
alert compared to those who had an incident alert on the ICU (35%, p<0.001), and was 
significantly higher in HA-AKI (45.3%) alerting patients compared to CA-AKI (39.5%) 
alerting patients transferred to ICU (p=0.01).  Higher hazard of death was associated 
with older age (HR, 1.019; 95% CI, 1.016-1.023; p<0.001) and more severe AKI at 
presentation (AKI 2/3 versus AKI; HR, 1.27; 95% CI, 1.15-1.40; p<0.001). Adjusted for 
these variables the HR of death was higher in patients transferred to ICU following the 
alert compared to those who had an incident alert on the ICU (adjusted HR, 1.22; 95% 
CI, 1.12-1.34; p<0.001).  
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In contrast to mortality, in the surviving patients, the proportion of patients recovering 
renal function (i.e. death censored renal survival) following an AKI episode, was 
significantly higher in HA-AKI alerting (84.2%, p=0.004) and CA-AKI alerting patients 
(87.6%, p<0.001) compared to patients alerting on the ICU (78.3%).   
 
Definitional e-ǲǳǤ 
Table 2 compares the characteristics of the rule 1, rule 2 and rule 3 alerting cohorts. 
Rule 3, accounted for 45.8%, rule 2 37.3% and rule 1 only 16.8% of all incident alerts.  
Rule 1 and 2 detected 77.3% of HA-AKI incident alerts whilst 85.2% of CA-AKI incident 
alerts were detected by rule 3.  Rule 3 also identified 48.1% of all acute on chronic 
kidney injury (A-CKI) alerts, although it is of note that the majority of rule 1 alerts 
represented A-CKI alerts (53.2%).  By the definitional rules, rule 1 AKI alerts are all 
stage 1 AKI.  Rule 3 alerts identified a significantly higher proportion of AKI stage 2 and 
stage 3 than rule 2 (p<0.001), with 57.7% of all AKI stage 2 and 84.3% of all AKI stage 3 
being identified by rule 3 alerts.    
Reflecting the level of AKI severity, 90-day mortality for AKI treated in ICU was 
significantly higher for rule 2 (p=0.008) and rule 3 (p<0.001) alerts than rule 1 alerts 
(mortality was not significantly different for rule 2 and rule 3 alerts).  Similarly, the 
proportion of patients recovering renal function was highest following a rule 1 alert 
(89.5%, p<0.001 vs. rule 2 and p=0.04).   
 
Discussion 
Although it is widely recognised that AKI is commonly associated with serious illness, 
there is a wide variation in reported incidence in the context of ICU (10-15).  There are 
limited published data describing patterns of AKI in ICU across the whole spectrum of 
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injury, with many key studies focused on severe AKI and patients requiring renal 
replacement therapy (16-18).  In some previously published studies the diagnosis of 
AKI is reliant on a clinical diagnosis, hospital coding or retrospective review of hospital 
records (1-4).  Other studies have used a creatinine based diagnosis of AKI, but in the 
absence of any creatinine values in the preceding 3 months (accounting for more than 
half of the patients in some studies) baseline estimations of renal function were made 
by solving the Modification of Diet in Renal Disease (MDRD) equation (15, 19).  In this 
study we set out to determine if a centralised data set based on electronic AKI e-alerts 
using the ǯ own historical baseline in all cases, provides a reliable method to 
characterise AKI in the ICU setting.   
From our data AKI requiring the services of ICU accounts for 10% of all incident 
episodes of AKI identified by a biochemistry based e-alert.  This finding is consistent 
with a population-based study in Scotland in which 9.5% of patients with AKI were 
treated in the ICU (20),  and in which a retrospective diagnosis of AKI was defined by a  
change in creatinine criteria.   Our overall mortality was also consistent with previous 
published data (19), and also confirms the association of higher mortality with AKI Ǯǯ(16, 21, 22).  This agreement 
with previous studies using a variety of methods to identify AKI, suggests that using AKI 
alerts to generate a platform from which the epidemiology of AKI can be built is valid 
despite the use of baseline data on renal function which is reliant in almost half of cases 
on a median value of results from the preceding 365 days (rule 3).   
It is of note that while increased severity of AKI in the ICU population is associated with 
increased mortality, for the surviving patients, non recovery of renal function only 
occurs in a minority of patients. This is also consistent with previously published data 
suggesting that severity of AKI in the ICU, assessed by changes in creatinine, predicts 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 9 
short term patient survival but does not impact longer term renal outcome, which is in 
contrast to non-ICU populations (23).  
It is important to recognise that clinically, AKI in the setting of ICU is likely to represent 
a diverse patient group.  In this study AKI developing in the ICU represents only half of 
all AKI treated in the ICU.  This is consistent with published data by the NEFROINT 
investigators reporting of AKI incidence in ICU in Italy (15). Our data suggest that 
patients in which AKI is diagnosed in the ICU and those in which AKI is identified prior 
to transfer to the ICU either within the hospital or in a community setting represent 
different cohorts, with differing AKI stages at presentation being associated with 
different outcomes in each cohort. There was a higher proportion of AKI stage 2 and 3 in 
those transferred to ICU with AKI, from both in hospital settings and the community, 
compared to those developing AKI in the ICU. This suggests that AKI outside the ICU is 
detected later in the course of the AKI episode. Patients once admitted to the ICU are 
more likely to have routine surveillance of their biochemical parameters which results 
in early detection of small increments in serum creatinine. These different patterns of 
presentation are also reflected in different outcomes with a higher mortality in both 
groups of patients transferred to ICU following AKI identification.   
Confidence in the accurate determination of baseline kidney function is important to 
convince clinicians of the validity and clinical utility of an automated electronic AKI 
alert.  Current agreed AKI definitions such as The Acute Kidney Injury Network 
definition rely on a rolling 48-hour window of detection for AKI (24).  The use of 
historical baseline values may therefore not be widely accepted by clinicians.  Using 
strict definitions that do not take into account pre-admission biochemical results to 
alert AKI are however likely to severely underestimate AKI incidence (25), and result in 
delays in identification of AKI. Concerns have however been raised that the use of 
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automated alerts may have unintended consequences related to over-diagnosis leading 
to overtreatment (26).   In this manuscript we have demonstrated that in the context of 
ICU treated AKI identified by an electronic alert, Rule 3 alerts generated by rises in 
creatinine from the median of results from the previous 8 to 365 days, which therefore 
does not conform to the strict definition of AKI, generates the largest cohort of 
electronic alerts, the highest proportion of stage 2 and 3 AKI, and 85% of all AKI which 
develops in the community.  Furthermore this rule, representing the furthest ǲǳ          ality reflecting the 
higher AKI severity.  Suppression of this rule therefore would lead to a missed 
opportunity of AKI in patients presenting at the hospital front door requiring ICU 
support, which may therefore lead to missed opportunities for early intervention to 
influence outcome.  The current electronic AKI alerting     ǲǳ
highlights high risk patients who require additional clinical scrutiny.   
Although this study is to our knowledge the first national study using an e-alert based 
system to characterise AKI in the ICU its findings need to be qualified by its limitations. 
Whilst using the centralised data collection simplifies data collection and reduces the 
burden on busy clinicians, it precludes inclusion of clinical information, such as patient 
co-morbidity and linkage to primary care data sets, and lacks the detail of the cause of 
AKI and does not shed light on the cause of death. As a result, we are unable to collect 
data related to clinical variables which influence both AKI pathophysiology of AKI and 
outcome.  We are unable to report on the initiation of Renal Replacement Therapy 
(RRT), which impacts on the interpretation on progression of AKI stage as early 
initiation of RRT to manage fluid balance may result in reductions/stabilisation of 
creatinine resultant from RRT.  Our definition of AKI whilst based on serial changes in 
serum creatinine does not take into account urine output based AKI diagnosis which 
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results in under-reporting of the true incidence of AKI (13, 27).   It should also be 
acknowledged that using recovery of renal function based on serum creatinine may lead 
to an overestimation of renal function in the critically ill as a result of muscle wasting 
(28).  Finally, outcome data is limited to 90 days.  Longer term follow-up is therefore 
needed to describe the association with progressive CKD.   The strengths of the study 
are the use of a large national data set which uses electronic alerts in which AKI      ǯ   ǡ    
contemporary view of AKI across a whole population, and the inclusion of the whole 
spectrum of AKI disease severity. Moreover, this multicentre study covers the whole of 
the adult population of Wales therefore avoiding any bias of centre selection.   The study 
demonstrates that using AKI e-alerts provides an opportunity to prospectively collect 
data using a centralised resource which does not rely on either clinical diagnosis of AKI 
nor coding data.  This approach therefore provides a mechanism to generate a 
comprehensive data set to define the incidence and outcome of AKI in the ICU setting.   
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Table 1. Characteristics of AKI episodes requiring the Intensive Care Unit (ICU). 
 
Variable ICU 
n (% of all incident alerts) 4746 (10.0) 
Mean age ±SD (yr) 66.4 ±15.0 
Sex 
Male 58.7 (2786) 
Female 41.2 (1960) 
Pre-existing CKD, % (n) 28.0 (1321) 
Mean baseline SCr ±SD (µmol/L) 88.6 ±48.2 
Mean baseline eGFR ±SD 
(ml/min/1.73m²) 
78.4 ±30.4 
Mean alert SCr ±SD (µmol/L) 182.1 ±146.7 
AKI Severity, % (n) 
Stage 1 70.3 (3337) 
Stage 2 17.2 (816) 
Stage 3 12.5 (593) 
Progression of AKI, % (n) 38.5 (1829) 
Mean peak SCr±SD(µmol/L) 240.6 ±180.4 
90-day mortality, % (n) 38.1 (1664) 
Renal Recovery, % (n) 82.3 (2512) 
Baseline eGFR data were missing for 35 episodes) and 
excluded from analysis of the Pre-existing CKD variable. 
Mortality data was available for 4362 episodes. SCr follow 
up data was available for 3053 episodes) and included in 
analysis of the recovery variable. PeCKD, Pre-existing 
chronic kidney disease; SCr, Serum creatinine; ICU, 
Intensive Care Unit.   
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Table 2. Comparison of patients whose AKI was identified in ICU vs. HA-AKI patients 
transferred to ICU following an AKI e-alert vs. CA-AKI patients transferred to ICU 
following an AKI e-alert. 
 
Variable AKI identified 
in ICU 
HA-AKI 
transferred to 
ICU 
CA-AKI 
transferred to 
ICU 
 
n (% of episodes requiring 
ICU) 
2318 (48.8) 835 (17.6) 1373 (28.9)  
Mean age ±SD (yr) 66.9 ±14.6 68.3 ±14.5 64.2 ±15.8  
Sex 
Male 61.2 (1419) 58.1 (485) 55.6 (763) 
 
Female 38.7 (899) 41.9 (350) 44.4 (610) 
Pre-existing CKD, % (n) 26.0 (598) 30.1 (250) 29.5 (404)  
Mean baseline SCr ±SD 
(µmol/L) 
86.0 ±48.7 88.3 ±46.4 92.6 ±49.4  
Mean alert SCr ±SD 
(µmol/L) 
144.9 ±77.8 160.6 ±83.4 245.2 ±207.0  
AKI Severity, % (n) 
Stage 1 82.1 (1902) 73.4 (613) * 52.0 (714) * # 
*P<0.001 vs. in ICU 
#p<0.001 vs. HA-AKI Stage 2 13.6 (315) 18.0 (150)* 21.7 (298) ) * # 
Stage 3 4.4 (101) 8.6 (72)* 26.3 (361) ) * # 
AKI Rule, % (n) 
Rule 1 25.8 (599) 17.5 (146) 3.7 (51) 
 Rule 2 51.3 (1189) 50.5 (422) 11.1 (152) 
Rule 3 22.9 (530) 32.0 (267) 85.2 (1170) 
Progression of AKI, % (n) 41.0 (951) 49.1 (410) * 28.7 (394) ) *# 
*P<0.001 vs. in ICU 
#p<0.001 vs. HA-AKI 
Mean peak 
SCr±SD(µmol/L) 
204.5 ±139.2 234.3 ±142.1 294.2 ±226.8  
90-day mortality, % (n) 35.0 (763) 45.3 (343)* 39.5 (484) Ș ? *P<0.001 vs. in-ICU Ș ? ?Ǥ ? ? ?vs. in-ICU 
#p=0.01 vs. HA-AKI 
Recovery, % (n) 78.3 (1204) 84.2 (410)* 87.6 (775)* *P<0.001 vs. in ICU 
Baseline eGFR data were missing for 35 episodes (24, AKI identified in ICU; 5, HA-AKI transferred to ICU; 4, CA-AKI 
transferred to ICU) and excluded from analysis of the Pre-existing CKD variable. Mortality data was available for 4362 
episodes (2177, AKI identified in ICU; 757, HA-AKI transferred to ICU; 1225, CA-AKI transferred to ICU). SCr follow up data 
was available for 3053 episodes (1538, AKI identified in ICU; 487, HA-AKI transferred to ICU; 885, CA-AKI transferred to 
ICU) and included in analysis of the Recovery variable. HA-AKI, Hospital acquired AKI; CA-AKI, Community acquired AKI; 
PeCKD, Pre-existing chronic kidney disease; SCr, Serum creatinine; ICU, Intensive Care Unit.   
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Table 3. Characteristics and outcomes for the Rule 1, Rule 2 and Rule 3 cohorts for AKI 
episodes treated on the Intensive Care Unit (ICU). 
 
 Rule 1 Rule 2 Rule 3  
n (% of ITU cohort) 798 (16.8) 1772 (37.3) 2176 (45.8)  
Mean age ±SD (yr) 70.1 ±14.0 66.0 ±15.9 65.2 ±15.4  
Sex, % of ICU cohort  (n) 
Male 69.0 (551) 55.3 (980) 57.7 (1255)  
Female 31.0 (247) 44.7 (792) 42.3 (921)  
Pre-existing CKD, % (n) 53.2 (413) 15.4 (272) 29.3 (636)  
Mean baseline SCr ±SD 
(µmol/l) 
122.0 ±58.0 69.1 ±30.7 92.4 ±48.5 
 
Mean alert SCr ±SD (µmol/l) 161.7 ±67.3 130.1 ±62.3 231.8 ±193.1  
AKI Severity, % (n) 
Stage 1 100.0 (798) 75.3 (1334)* 55.4 (1205)*# 
*P<0.001 vs. rule 1 
#p<0.001 vs. rule 2 
Stage 2 
 
19.5 (345)* 21.6 (471)*# 
Stage 3 
 
5.2 (93)* 23.0 (500)*# 
ICU classification, % (n) 
AKI identified in ICU 75.1 (599) 67.1 (1189) 24.4 (530)  
HA-AKI transferred to ICU 18.3 (146) 23.8 (422) 12.3 (267)  
CA-AKI transferred to ICU 6.4 (51) 8.6 (152) 53.8 (1170)  
Progression of AKI, % (n) 32.6 (260) 47.2 (836)* 33.7 (733) 
*p=0.008 vs. rule1 
and rule 3 
Mean peak SCr ±SD (µmol/l) 227.3 ±130.9 190.8 ±134.1 286.1 ±214.4  
90-day mortality, % (n) 32.5 (244) 38.2 (628)* 40.3 (792)# 
*p=0.008 vs. rule1 
#p<0.001 vs. rule 1 
Recovery, % (n) 89.5 (485) 74.2 (1136)* 86.1 (1184) ?Ș *p<0.001vs rule1 #p=0.04 vs. rule 1 Ș ? ? ?Ǥ ? ? ?vs. rule 
2 
Baseline eGFR data were missing for 25 episodes (11, Rule 1; 8, Rule 2; 6, Rule 3) and excluded from analysis of the 
Pre-existing CKD variable. Mortality data was available for 4362 episodes (750, Rule 1; 1646, Rule 2; 1966, Rule 3). 
SCr follow up data was available for 3053 episodes (542, Rule 1; 1136, Rule 2; 1375, Rule 3) and included in 
analysis of the recovery variable. 220 incident episodes of AKI were excluded from analysis of the ICU classification 
variable as it was not possible to classify as HA/CA or ICU AK. I HA-AKI, Hospital acquired AKI; CA-AKI, Community 
acquired AKI; PeCKD, Pre-existing chronic kidney disease; SCr, Serum creatinine; ICU, Intensive Care Unit.   
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Highlights 
x Data on epidemiology of AKI historically is reliant on coding or retrospective clinical 
diagnosis 
x We describe the epidemiology of AKI in the ICU based an electronic AKI alert based 
on a change in creatinine diagnosis of AKI 
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